Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.52 USD | +1.57% | -1.09% | -31.72% |
15/04 | TELA Bio, Inc. Announces U.S. Commercial Launch of Robotic-Compatible OviTex IHR | CI |
22/03 | Piper Sandler Adjusts Price Target on TELA Bio to $12 From $15, Maintains Overweight Rating | MT |
Business Summary
Number of employees: 227
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Soft-tissue Reconstruction Solutions
100.0
%
| 41 | 100.0 % | 58 | 100.0 % | +41.13% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 41 | 100.0 % | 58 | 100.0 % | +41.13% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Antony Koblish
FOU | Founder | 58 | 17/12/17 |
Roberto Cuca
DFI | Director of Finance/CFO | 57 | 27/21/27 |
Marissa Conrad
CTO | Chief Tech/Sci/R&D Officer | - | 24/21/24 |
Paul Talmo
CTO | Chief Tech/Sci/R&D Officer | 57 | 01/14/01 |
Investor Relations Contact | - | - | |
D. Taylor Ocasio
LAW | General Counsel | - | 18/22/18 |
Megan Smeykal
AUD | Comptroller/Controller/Auditor | 48 | 01/19/01 |
Bruce Freedman
PRN | Corporate Officer/Principal | - | 01/21/01 |
Peter Murphy
PRN | Corporate Officer/Principal | 52 | 29/20/29 |
Michael Leonard
PRN | Corporate Officer/Principal | - | 01/18/01 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Lisa Colleran
BRD | Director/Board Member | 66 | 20/20/20 |
Douglas Evans
CHM | Chairman | 59 | 20/20/20 |
Antony Koblish
FOU | Founder | 58 | 17/12/17 |
Vince Burgess
BRD | Director/Board Member | 59 | 01/14/01 |
Federica O’Brien
BRD | Director/Board Member | 66 | 13/19/13 |
Kurt Azarbarzin
BRD | Director/Board Member | 61 | 06/18/06 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 24,653,939 | 22,995,548 ( 93.27 %) | 0 | 93.27 % |
Company contact information
Sector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-31.72% | 111M | |
-2.54% | 186B | |
-1.85% | 107B | |
-4.26% | 67.44B | |
+1.39% | 50.03B | |
+16.82% | 47.81B | |
+4.79% | 41.03B | |
+3.49% | 26.85B | |
+0.65% | 25.82B | |
+16.55% | 24.74B |
- Stock Market
- Equities
- TELA Stock
- Company TELA Bio, Inc.